UAL
73
3
DTE
49
16
JBHT
46
4
KO
44
2
PCG
59
9
AIG
38
5
DNB
72
4
CSCO
63
5
GOOG
77
14
MMC
46
5
VRSN
59
4
URBN
67
3
RCL
74
5
MPC
28
3
FSLR
50
6
SNA
56
3
HST
53
4
UPS
51
6
MO
47
6
AKAM
50
2
UAL
73
3
DTE
49
16
JBHT
46
4
KO
44
2
PCG
59
9
AIG
38
5
DNB
72
4
CSCO
63
5
GOOG
77
14
MMC
46
5
VRSN
59
4
URBN
67
3
RCL
74
5
MPC
28
3
FSLR
50
6
SNA
56
3
HST
53
4
UPS
51
6
MO
47
6
AKAM
50
2
Financhill
Back

ADC Therapeutics SA 10K Form

Sell
24

ADCT
ADC Therapeutics SA

Last Price:
$1.97
Seasonality Move:
26.76%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ADCT News And Ratings

See the #1 stock for the next 7 days that we like better than ADCT

ADCT Financial Statistics

Sales & Book Value

Annual Sales: $69.6M
Cash Flow: $-25.3M
Price / Cash Flow: 0
Annual Sales: $-1.78
Price / Book: 0

Profitability

EPS (TTM): -2.40000
Net Income (TTM): $-212.2M
Gross Margin: $67M
Return on Equity: 0%
Return on Assets: -57.32%

ADC Therapeutics SA Earnings Forecast

Key ADC Therapeutics SA Financial Ratios

  • The Gross Profit Margin over the past 5 years for ADCT is 96.36%.
  • The Selling, General & Administrative Expenses for ADCT have been equal to 152.23% of Gross Profit Margin.
  • The Research & Development expenses have been 182.76% of Revenue.
  • The Interest Expense is -19.30% of Operating Income.
  • The Net Earning history of ADCT is -345.11% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 3 years.

ADC Therapeutics SA Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Biotechnology
Sector: Health Care
Current Symbol: ADCT
CUSIP: H0036K
Website: adctherapeutics.com

Debt

Debt-to-Equity Ratio: -0.66
Current Ratio: 4.92
Quick Ratio: 4.41

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ADCT Technical Analysis vs Fundamental Analysis

Sell
24
ADC Therapeutics SA (ADCT) is a Sell

Is ADC Therapeutics SA a Buy or a Sell?